296 related articles for article (PubMed ID: 27686408)
21. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.
Mellanby RJ; Thomas D; Phillips JM; Cooke A
Immunology; 2007 May; 121(1):15-28. PubMed ID: 17428252
[TBL] [Abstract][Full Text] [Related]
22. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.
Tisch R; Yang XD; Singer SM; Liblau RS; Fugger L; McDevitt HO
Nature; 1993 Nov; 366(6450):72-5. PubMed ID: 8232539
[TBL] [Abstract][Full Text] [Related]
23. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
24. Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy.
Qin HY; Elliott JF; Lakey JR; Rajotte RV; Singh B
J Autoimmun; 1998 Dec; 11(6):591-601. PubMed ID: 9878081
[TBL] [Abstract][Full Text] [Related]
25. Dynamic changes of the Th17/Tc17 and regulatory T cell populations interfere in the experimental autoimmune diabetes pathogenesis.
Yaochite JN; Caliari-Oliveira C; Davanso MR; Carlos D; Malmegrim KC; Cardoso CR; Ramalho LN; Palma PV; da Silva JS; Cunha FQ; Covas DT; Voltarelli JC
Immunobiology; 2013 Mar; 218(3):338-52. PubMed ID: 22704522
[TBL] [Abstract][Full Text] [Related]
26. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse.
Goldrath AW; Barber L; Chen KE; Alters SE
J Autoimmun; 1995 Apr; 8(2):209-20. PubMed ID: 7612149
[TBL] [Abstract][Full Text] [Related]
27. CD226 Deletion Reduces Type 1 Diabetes in the NOD Mouse by Impairing Thymocyte Development and Peripheral T Cell Activation.
Shapiro MR; Yeh WI; Longfield JR; Gallagher J; Infante CM; Wellford S; Posgai AL; Atkinson MA; Campbell-Thompson M; Lieberman SM; Serreze DV; Geurts AM; Chen YG; Brusko TM
Front Immunol; 2020; 11():2180. PubMed ID: 33013915
[TBL] [Abstract][Full Text] [Related]
28. Plasmacytoid dendritic cells license regulatory T cells, upon iNKT-cell stimulation, to prevent autoimmune diabetes.
Beaudoin L; Diana J; Ghazarian L; Simoni Y; Boitard C; Lehuen A
Eur J Immunol; 2014 May; 44(5):1454-66. PubMed ID: 24481989
[TBL] [Abstract][Full Text] [Related]
29. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
[TBL] [Abstract][Full Text] [Related]
30. L-selectin is not required for T cell-mediated autoimmune diabetes.
Friedline RH; Wong CP; Steeber DA; Tedder TF; Tisch R
J Immunol; 2002 Mar; 168(6):2659-66. PubMed ID: 11884430
[TBL] [Abstract][Full Text] [Related]
31. Genetic and immunological basis of autoimmune diabetes in the NOD mouse.
Yoshida K; Kikutani H
Rev Immunogenet; 2000; 2(1):140-6. PubMed ID: 11324686
[TBL] [Abstract][Full Text] [Related]
32. Administration of a determinant of preproinsulin can induce regulatory T cells and suppress anti-islet autoimmunity in NOD mice.
Arai T; Moriyama H; Shimizu M; Sasaki H; Kishi M; Okumachi Y; Yasuda H; Hara K; Yokono K; Nagata M
Clin Immunol; 2010 Jul; 136(1):74-82. PubMed ID: 20359955
[TBL] [Abstract][Full Text] [Related]
33. The B-subunit of cholera toxin induces immunoregulatory cells and prevents diabetes in the NOD mouse.
Sobel DO; Yankelevich B; Goyal D; Nelson D; Mazumder A
Diabetes; 1998 Feb; 47(2):186-91. PubMed ID: 9519711
[TBL] [Abstract][Full Text] [Related]
34. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis.
Matsumoto M; Yagi H; Kunimoto K; Kawaguchi J; Makino S; Harada M
Cell Immunol; 1993 Apr; 148(1):189-97. PubMed ID: 8098666
[TBL] [Abstract][Full Text] [Related]
35. Haploinsufficiency of interferon regulatory factor 4 strongly protects against autoimmune diabetes in NOD mice.
Akazawa S; Kobayashi M; Kuriya G; Horie I; Yu L; Yamasaki H; Okita M; Nagayama Y; Matsuyama T; Akbari M; Yui K; Kawakami A; Abiru N
Diabetologia; 2015 Nov; 58(11):2606-14. PubMed ID: 26271342
[TBL] [Abstract][Full Text] [Related]
36. Interaction of dendritic cells and T lymphocytes for the therapeutic effect of Dangguiliuhuang decoction to autoimmune diabetes.
Liu T; Cao H; Ji Y; Pei Y; Yu Z; Quan Y; Xiang M
Sci Rep; 2015 Sep; 5():13982. PubMed ID: 26358493
[TBL] [Abstract][Full Text] [Related]
37. Pancreatic lymph nodes are required for priming of beta cell reactive T cells in NOD mice.
Gagnerault MC; Luan JJ; Lotton C; Lepault F
J Exp Med; 2002 Aug; 196(3):369-77. PubMed ID: 12163565
[TBL] [Abstract][Full Text] [Related]
38. Sodium meta-arsenite prevents the development of autoimmune diabetes in NOD mice.
Lee YS; Kim D; Lee EK; Kim S; Choi CS; Jun HS
Toxicol Appl Pharmacol; 2015 Apr; 284(2):254-61. PubMed ID: 25576766
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
40. Effects of insulin like growth factor-1 and insulin on effector T cells generating autoimmune diabetes.
Bergerot I; Fabien N; Thivolet C
Diabetes Metab; 1996 Jul; 22(4):235-9. PubMed ID: 8767168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]